Kenro Hirata
ORCID: 0000-0003-4536-7781
· 2 papers in corpus
Abstract Background Immune checkpoint inhibitors have been approved for various types of cancer; however, they cause a broad spectrum of immune-related adverse events (irAEs). The association between the development of irAEs and the clinic…